EUVIMEDEUVIMED entdecken
Vergleichsstudie

Safety and efficacy of multiple-dose versus single-dose MIBG therapy in patients with refractory pheochromocytoma and paraganglioma: a single-center retrospective analysis

Naoto Wakabayashi, Shiro Watanabe, Takashige Abe, Junki Takenaka, Kenji Hirata, Rina Kimura, Keita Sakamoto, Nobuo Shinohara, Kohsuke Kudo

Annals of Nuclear Medicine · 2024

DOI: 10.1007/s12149-024-01928-2 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Annals of Nuclear Medicine, 2024. Verfasst von Naoto Wakabayashi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Hokkaido University Hospital, Kita14, Nishi5, Kita-Ku, Sapporo, Hokkaido, 060-8648, Japan. Hauptthemen laut MEDLINE: 3-Iodobenzylguanidine, Pheochromocytoma, Paraganglioma, Adrenal Gland Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

3-IodobenzylguanidinePheochromocytomaParagangliomaAdrenal Gland NeoplasmsHumansRetrospective StudiesMaleFemaleMiddle AgedAdultAgedTreatment OutcomeYoung Adult

Stichwörter der Autor:innen

EfficacyMIBGParagangliomaPheochromocytomaSafety

Substanzen

3-Iodobenzylguanidine

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Hokkaido University Hospital, Kita14, Nishi5, Kita-Ku, Sapporo, Hokkaido, 060-8648, Japan.
  • Department of Diagnostic and Interventional Radiology, Hokkaido University Hospital, Kita14, Nishi5, Kita-Ku, Sapporo, Hokkaido, 060-8648, Japan.
  • Department of Diagnostic Imaging, Graduate School of Medicine, Hokkaido University, Kita15, Nishi7, Kita-Ku, Sapporo, Hokkaido, 060-8638, Japan.
  • Department of Nuclear Medicine, Hokkaido University Hospital, Kita14, Nishi5, Kita-Ku, Sapporo, Hokkaido, 060-8648, Japan. shirow@med.hokudai.ac.jp.
  • Department of Diagnostic Imaging, Graduate School of Medicine, Hokkaido University, Kita15, Nishi7, Kita-Ku, Sapporo, Hokkaido, 060-8638, Japan. shirow@med.hokudai.ac.jp.
  • Department of Renal and Genitourinary Surgery, Hokkaido University Graduate School of Medicine, Kita15, Nishi7, Kita-Ku, Sapporo, Hokkaido, 060-8638, Japan.

Zitieren

APA

Wakabayashi, N., Watanabe, S., Abe, T., Takenaka, J., Hirata, K., Kimura, R., Sakamoto, K., Shinohara, N., & Kudo, K. (2024). Safety and efficacy of multiple-dose versus single-dose MIBG therapy in patients with refractory pheochromocytoma and paraganglioma: a single-center retrospective analysis. Annals of Nuclear Medicine. https://doi.org/10.1007/s12149-024-01928-2

Vancouver

Wakabayashi N, Watanabe S, Abe T, Takenaka J, Hirata K, Kimura R, et al. Safety and efficacy of multiple-dose versus single-dose MIBG therapy in patients with refractory pheochromocytoma and paraganglioma: a single-center retrospective analysis. Annals of Nuclear Medicine. 2024. doi:10.1007/s12149-024-01928-2

BibTeX
@article{Wakabayashi2024,
  author = {Wakabayashi, Naoto and Watanabe, Shiro and Abe, Takashige and Takenaka, Junki and Hirata, Kenji and Kimura, Rina and Sakamoto, Keita and Shinohara, Nobuo and Kudo, Kohsuke},
  title = {Safety and efficacy of multiple-dose versus single-dose MIBG therapy in patients with refractory pheochromocytoma and paraganglioma: a single-center retrospective analysis},
  journal = {Annals of Nuclear Medicine},
  year = {2024},
  doi = {10.1007/s12149-024-01928-2}
}
Kostenlos starten →